Free Trial
LON:INDV

Indivior (INDV) Share Price, News & Analysis

Indivior logo
GBX 1,142 +11.00 (+0.97%)
As of 07/11/2025 11:49 AM Eastern

About Indivior Stock (LON:INDV)

Key Stats

Today's Range
1,117
1,147
50-Day Range
825.50
1,145
52-Week Range
548.71
1,161
Volume
147,132 shs
Average Volume
764,903 shs
Market Capitalization
£1.78 billion
P/E Ratio
N/A
Dividend Yield
1.31%
Price Target
GBX 1,650
Consensus Rating
Buy

Company Overview

Indivior Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

INDV MarketRank™: 

Indivior scored higher than 48% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Indivior has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Indivior has received no research coverage in the past 90 days.

  • Read more about Indivior's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Indivior is -946.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Indivior is -946.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Due to a projected decrease in earnings for Indivior, their PEG ratio cannot be calculated.

  • Short Interest

    There is no current short interest data available for INDV.
  • Dividend Leadership

    Indivior is a leading dividend payer. It pays a dividend yield of 4.48%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Indivior does not have a long track record of dividend growth.

  • Read more about Indivior's dividend.
  • Short Interest

    There is no current short interest data available for INDV.
  • Search Interest

    1 people have searched for INDV on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Indivior insiders have bought more of their company's stock than they have sold. Specifically, they have bought £80,157 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    Only 3.44% of the stock of Indivior is held by insiders.

  • Percentage Held by Institutions

    85.98% of the stock of Indivior is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Indivior's insider trading history.
Receive INDV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

INDV Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

INDV Stock Analysis - Frequently Asked Questions

Indivior's stock was trading at GBX 1,024 at the beginning of the year. Since then, INDV shares have increased by 11.5% and is now trading at GBX 1,142.

Shares of INDV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Indivior investors own include Futura Medical (FUM), Bigblu Broadband (BBB), Directa Plus (DCTA), Lakehouse (LAKE), Kingfisher (KGF), Sirius XM (SIRI) and Aquila Services Group (AQSG).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:INDV
CIK
N/A
Fax
N/A
Employees
1,000
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 1,800
Low Price Target
GBX 1,500
Potential Upside/Downside
+44.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (1.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
1,077.36
P/E Growth
-5.57
Net Income
-£2.36 million
Net Margins
-0.17%
Pretax Margin
N/A
Return on Equity
-0.77%
Return on Assets
2.37%

Debt

Debt-to-Equity Ratio
-170.06
Current Ratio
0.83
Quick Ratio
1.52

Sales & Book Value

Annual Sales
£1.40 billion
Price / Sales
1.28
Cash Flow
GBX 426.10 per share
Price / Cash Flow
2.68
Book Value
GBX (126.42) per share
Price / Book
-9.03

Miscellaneous

Outstanding Shares
156,209,528
Free Float
N/A
Market Cap
£1.78 billion
Optionable
Not Optionable
Beta
0.19
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:INDV) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners